Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000262707
Ethics application status
Approved
Date submitted
25/02/2013
Date registered
5/03/2013
Date last updated
28/08/2014
Type of registration
Prospectively registered
Titles & IDs
Public title
Clinical Study of New Intraocular Lens Design in Participants requiring Bilaterial Cataract Removal
Query!
Scientific title
A Prospective, Non-randomised, Technician-masked, Parallel group (40-50 subjects), Dual site, Clinical Investigation of a new Intraocular Lens (model XRA03) when compared to the Control, Tecnis 1-piece Monofocal Lens (ZCB00) in participants requiring Bilaterial Cataract Removal to Assess Binocular Distance Vision Acuity and Incidence of Dysphotopsias.
Query!
Secondary ID [1]
281979
0
Nil
Query!
Universal Trial Number (UTN)
U111-1139-5832
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cataract extraction and artificial lens implantation for vision acuity restoration for far, intermediate and near vision with reduced need for further spectacle correction/dependence.
288408
0
Query!
Condition category
Condition code
Eye
288757
288757
0
0
Query!
Diseases / disorders of the eye
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
In Model XRA03, the spherical diffractive posterior surface of the lens optic has been modified to provide an increased range of vision and partially corrects for chromatic aberrations. After phacoemulsification/removal of a cataractous lens, the study device is implanted using a manual "Platinum 1" screw style Unfolder/handpiece through a minimally invasive (~2.4mm) corneal incision. A standard operative time is 30-40min. Once implanted, the design benefits are intended to be permanent.
Query!
Intervention code [1]
286551
0
Treatment: Devices
Query!
Comparator / control treatment
The control lenses are an approved monofocal hydrophobic acrylic Intraocular lens. Surgical approach for control device is identical to the study lens via phacoemulsification /extraction of the natural cataracterous lens followed by lens insertion through a minimally invasive (~2.4mm) corneal incision using a "Platinum1 " screw style Unfolder/ handpiece. A standard operative time is 30-40min.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
288896
0
Binocular range of vision. Subjects will read an eye chart situated at a various distances using both eyes.
Query!
Assessment method [1]
288896
0
Query!
Timepoint [1]
288896
0
Three months post-operative second lens implantation.
Query!
Secondary outcome [1]
301259
0
Sponsor developed Questionnaire assessment of patient satisfaction of vision quality, optical visual syptoms and spectacle usage administered by clinical staff.
Query!
Assessment method [1]
301259
0
Query!
Timepoint [1]
301259
0
Same as primary 3 months post operative second lens replacement.
Query!
Secondary outcome [2]
301260
0
Monocular and binocular uncorrected and best-corrected distance visual acuity. Subjects will read an eye chart situated at a far distance with and without spectacle correction using one eye at a time and both eyes.
Query!
Assessment method [2]
301260
0
Query!
Timepoint [2]
301260
0
Same as primary 3 months post operative second lens replacement.
Query!
Secondary outcome [3]
301261
0
Monocular and binocular distance-corrected intermediate visual acuity. Subjects will read an eye chart situated at an intermediate distance with correction using one eye at a time and both eyes.
Query!
Assessment method [3]
301261
0
Query!
Timepoint [3]
301261
0
Same as primary 3 months post operative second lens replacement.
Query!
Secondary outcome [4]
301262
0
Monocular and binocular distance corrected and best-corrected near visual acuity with minimum/threshold add. Subjects will read an eye chart situated at a near distance with correction using one eye at a time and both eyes. This will also be tested with correction that is equivalent to reading glasses.
Query!
Assessment method [4]
301262
0
Query!
Timepoint [4]
301262
0
Same as primary 3 months post operative second lens replacement.
Query!
Secondary outcome [5]
301263
0
Monocular best-corrected distance contrast sensitivity. Subjects will look at a contrast sensitivity eye chart (consisting of dark to light-colored lines) with correction and report what they see using one eye at a time.
Query!
Assessment method [5]
301263
0
Query!
Timepoint [5]
301263
0
Same as primary 3 months post operative second lens replacement.
Query!
Secondary outcome [6]
301264
0
Incidences of optical/ visual symptoms. Subjects will be asked whether they have experienced any specific types of visual symptoms and the observed intensity, if any since surgeries.
Query!
Assessment method [6]
301264
0
Query!
Timepoint [6]
301264
0
Same as primary 3 months post operative second lens replacement.
Query!
Eligibility
Key inclusion criteria
Bilateral cataracts for which phacoemulsification extraction and posterior IOL implantation have been planned for both eyes
Visual potential of Decimal 0.8 (Snellen 20/25) or better in each eye after cataract removal and IOL implantation
Signed informed consent
Query!
Minimum age
20
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Use of systemic or ocular medications that may affect vision (the use of any miotic agent is specifically contraindicated)
Acute or chronic disease or illness that would increase the operative risk or confound the outcome(s) of the study (e.g., uncontrolled, insulin-dependent diabetes, immunocompromised (including current or anticipated use of immunosuppressants), connective tissue disease, etc.)
Surgery that is not resolved/stable or may affect vision
Prior refractive surgery (LASIK, LASEK, RK, PRK, etc.)
Corneal abnormalities such as stromal, epithelial or endothelial dystrophies
Intraocular inflammation or recurrent ocular inflammatory condition
Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.)
Capsule or zonule abnormalities that may affect postoperative IOL centration or tilt, including pseudoexfoliation, trauma, or surgical complications (e.g. zonular rupture, eccentric anterior capsulorhexis)
Requiring an intraocular study lens power outside the available range of +16.0 to +28.0 D
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Enrolment via recommendation from PI/CI and meeting the acceptance criteria. Informed consent form provides detailed information on the potential benefits and risks associated with selection to participant in the trial.
Allocation of study lens not concealed. Subject can select to have the experimental lens implanted in both eyes.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Non- randomized
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Technician masked to prevent bias in post-operative measurements / lens performance. Investigator or designated trained clinician shall perform the biomicroscopic slit-lamp exam.
Query!
Phase
Phase 2
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
For visual acuity data, descriptive statistics will be the focus including mean, standard deviation (SD) and the 95% confidence intervals (C.I.) of the mean. All data will be reported by IOL group. Although some statistical comparisons will be performed between IOL groups, it is noted that statistical power is somewhat limited in this study due to the control group being small in size, thus the study focus is primarily to describe the performance of the study IOL. A statistical comparison between lens groups will also be performed using a one-sided, two-sample, t-test with an alpha set at 0.05. The null hypothesis is that the mean defocus range for Model XRA03 subjects is less than or equal to that for control subjects. For questionnaire data, the frequency and proportion of subjects with a given response will be reported by IOL group. For comparisons between IOL groups, for ordinal data, the Wilcoxon rank sum test will be used with the Fisher’s exact test used for categorical data. For questionnaire data two-sided testing will be used with alpha set at 0.05.
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
24/04/2013
Query!
Actual
13/05/2013
Query!
Date of last participant enrolment
Anticipated
16/06/2013
Query!
Actual
30/07/2013
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
4871
0
New Zealand
Query!
State/province [1]
4871
0
North Island
Query!
Funding & Sponsors
Funding source category [1]
286757
0
Commercial sector/Industry
Query!
Name [1]
286757
0
Abbott Medical Optics Inc
Query!
Address [1]
286757
0
1700 E. Saint Andrew Place
Santa Ana,
California 92705
Query!
Country [1]
286757
0
United States of America
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Abbott Medical Optics Inc
Query!
Address
1700 E. Saint Andrew Place
Santa Ana,
California 92705
Query!
Country
United States of America
Query!
Secondary sponsor category [1]
285538
0
Individual
Query!
Name [1]
285538
0
Dr Dean Corbett BSc, MBChB, FRANZCO
Query!
Address [1]
285538
0
Auckland Eye
8 St. Marks Road
Remuera 1050
Auckland.
Query!
Country [1]
285538
0
New Zealand
Query!
Other collaborator category [1]
277293
0
Individual
Query!
Name [1]
277293
0
Dr Neil Murray
Query!
Address [1]
277293
0
71 Fairy Springs Road,
Rotorua 3010
New Zealand
Query!
Country [1]
277293
0
New Zealand
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
288827
0
Northern A Health and Disability Ethics Committee
Query!
Ethics committee address [1]
288827
0
Venue: Novetel Ellerslie
72-112 Greenlane Rd East
Auckland
Query!
Ethics committee country [1]
288827
0
New Zealand
Query!
Date submitted for ethics approval [1]
288827
0
28/02/2013
Query!
Approval date [1]
288827
0
23/04/2013
Query!
Ethics approval number [1]
288827
0
13/NTA/30
Query!
Summary
Brief summary
The purpose of this clinical trial is to evaluate the binocular clinical performance of a design modification to the Tecnis Monofocal IOL, Model XRA03. Results will include descriptive statistics on the visual performance of Model XRA03 in bilaterally implanted subjects (post phacoemulsification of cataracts) over distance, intermediate and near vision. This study is a prospective, non-randomized, technician-masked, parallel-group study of 40-50 subjects across up to two investigative sites. Clinical Hypothesis: The study IOL, Model XRA03 will achieve a mean binocular distance visual acuity of 20/40 or better at each defocus point through -1.5 diopters with minimal levels of clinically significant dysphotopsias (night glare/halos) and potentially provide improved uncorrected intermediate to near vision compared to currently marketed monofocal acrylic lenses.
Query!
Trial website
Query!
Trial related presentations / publications
1. Koretz J.F., Kaufman P.L, Neider M.W. Goeckner P.A. Accommodation and Presbyopia in the Human Eye – Aging of the Anterior Segment. Vision Res. 1989, Vol. 29, No. 12, pages 1685-1692.
2. Benjamin, William, J., Borish, Irvin M. Borish’s Clinical Refraction, Philadelphia: 1998, W.B. Saunders, pg 109.
Query!
Public notes
Results of this study will help determine the design for a larger clinical study that can support market approval and claims for Model XRA03 IOL.
Query!
Contacts
Principal investigator
Name
37950
0
Dr Dean Corbett BSc MBChB, FRANZCO
Query!
Address
37950
0
Auckland Eye
8 St. Mark's Road
Remuera 1050
Auckland.
Query!
Country
37950
0
New Zealand
Query!
Phone
37950
0
+64 9 529 2480
Query!
Fax
37950
0
+64 9 529 2481
Query!
Email
37950
0
[email protected]
Query!
Contact person for public queries
Name
37951
0
Dr Dean Corbett BSc MBChB, FRANZCO
Query!
Address
37951
0
Auckland Eye
8 St. Mark's Road
Remuera 1050
Auckland.
Query!
Country
37951
0
New Zealand
Query!
Phone
37951
0
+64 9 529 2480
Query!
Fax
37951
0
+64 9 529 2481
Query!
Email
37951
0
[email protected]
Query!
Contact person for scientific queries
Name
37952
0
Dr Eugenia Thomas
Query!
Address
37952
0
Senior Manager Clinical Research
Abbott Medical Optics Inc
1700 E. Saint Andrew Place
Santa Ana, California 92705
Query!
Country
37952
0
United States of America
Query!
Phone
37952
0
+1 (714) 247-8723
Query!
Fax
37952
0
+1 (714) 247-8784
Query!
Email
37952
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF